Study: SGX301 Demonstrates Efficacy for Treatment of Cutaneous T-cell Lymphoma
May 6th 2021New data from a phase 3 study evaluating SGX301 for treatment of cutaneous T-cell lymphoma (CTCL) skin symptoms was recently presented at the American Academy of Dermatology Virtual Meeting Experience (AAD VMX 2021).